Abstract
The effect of estradiol (E2) on rat tuberoinfundibular dopaminergic (TIDA) neurons was examined in vivo, employing chronic intraventricular (icv) infusion technique using an osmotic mini-pump. The activity of TIDA neurons was assessed by the release and synthesis of prolactin (PRL) in the rat pituitary gland and by the changes in the 3, 4-dihydroxyphenylacetic acid (DOPAC) and dopamine (DA) levels and in the DOPAC/DA ratio in the rat hypothalamus. We also examined the [3H] E2 binding in the rat hypothalamus. Ovariectomized female Wistar rats with E2 replacement were treated with daily icv infusion of 1μM of E2 or saline vehicle for 1, 3, and 7 days using the Alzet osmotic mini-pump and brain infusion kit. At 1 day of icv infusion of E2, the serum PRL level was significantly decreased compared with that in the vehicle group. Northern blot analysis of the total RNA isolated from the pituitary glands demonstrated a decrease in the PRL gene transcript level in the E2 group. At 3 days of E2 treatment, however, the serum PRL level was significantly increased compared with that of the vehicle-injected group and Northern blot analysis also demonstrated that the PRL gene transcript level was increased in the E2 group. At 7 days of E2 administration, there were no significant differences between the E2 and vehicle groups in either serum PRL or PRL gene transcript levels. There was a significant increase in the DOPAC/DA ratio after 1 day in the E2 group. However, no significant effects of E2 on this ratio were observed at 3 and 7 days of treatment. The DOPAC concentration in the E2 group was significantly increased at day 1 and significantly decreased at day 3, compared with that of the respective time in vehicle group. At day 7 there was no significant change in DOPAC concentration in either groups. The DA concentrations in the hypothalamus was not changed on any day in either group. Specific [3H] E2 binding was observed in the rat hypothalamus. These data suggest that E2 may have a biphasic effect on the accumulation of PRL gene transcripts and on the PRL secretion in the rat pituitary by first stimulating and then inhibiting the TIDA neuronal activity.
Similar content being viewed by others
References
Fuxe K. Cellular localization of monoamines in the median eminence and in the infundibular stem of some animals. Acta Physiol. Scand. 58: 383, 1963.
Birge CA., Jacobs L.S., Hammer C.T., Daughaday W.H. Catecholamine inhibition of PRL secretion by isolated rat adenohypophyses. Endocrinology 86: 120, 1970.
MacLeod R.M., Fomtham E.H., Lehmeyer J.E. PRL and growth hormone production as influenced by catecholamine and agents that affect brain catecholamine. Neuroendocrinology 6: 283, 1970.
Creese I., Schneider R., Snyder S.H. 3H-spiroperidol labels DA receptors in pituitary and brain. Eur. J. Pharmacol. 46: 337, 1977.
Cronin M.J., Weiner R.I. 3H-spiroperidol (Spiperone) binding to a putative DA receptor in sheep and steer pituitary and stalk median eminence. Endocrinology 104: 307, 1979.
Goldsmith P.C., Cronin M.J., Weiner R.I. DA receptor sites in the anterior pituitary. Histochemistry and Cytochemistry 40: 272, 1979.
Crrillo A.J., Steger R.W., Chamness G.C. DArgic stimulation of pituitary but not hypothalamic estrogen receptors in ovariectomized rats. Endocrinology 112: 1839, 1983.
Sar M. E2 is concentrated in tyrosine hydroxylase-containing neurons of the hypothalamus. Science 223: 938, 1984.
MacLeod R.M., Abad M., Eidson L.L. In vivo effect of sex hormones on the vitro synthesis of PRL and growth hormone in normal and pituitary tumor-bearing rats. Endocrinology 84: 1475, 1969.
Stone R.T., Maurer R.A., Gorski J. Effect of E2-17β on prePRL messenger ribonucleic acid activity in the rat pituitary gland. Biochemistry 16: 4915, 1977.
Vician L., Shupnik M.A., Gorski J. Effect of estrogen on primary ovine pituitary cell cultures: stimulation of PRL secretion, synthesis, and prePRL messenger ribonucleic acid activity. Endocrinology 104: 736, 1979.
Ferland L., Labrie F., Euvrard C., Raymond J.P. AntiDArgic activity of estrogens on PRL release at the pituitary level in vivo. Mol. Cell. Endocrinol. 14: 199, 1979.
Pasqualini C., Boida F., Kerdelhue B. Direct effect of E2 on the number of DA receptors in the anterior pituitary of ovariectomized rats. Endocrinology 119: 2484, 1986.
Raymond V., Beaulieu M., Labirie F. Potent antiDArgic activity of E2 at the pituitary level on PRL release. Science 200: 1173, 1978.
Ikegami H., Jikihara H., Koike K., Morishige K., Kurachi H., Yamamoto N., Hirota K., Miyake A., Tanizawa O. Intraventricular administration of thyrotropin-releasing hormone (TRH) suppresses PRL secretion and synthesis: a possible involvement of DA release by TRH from rat hypothalamus. J. Endocrinol. 133: 59, 1992.
Jikihara H., Ikegami H., Koike K., Wada W., Morishige K., Kurachi H., Hirota K., Miyake A., Tanizawa O. Intraventricular administration of cyclo (His-Pro) suppresses PRL secretion and synthesis: A possible role of cyclo (His-Pro) as DA uptake blocker in rat hypothalamus. Endocrinology 132: 953, 1993.
Konig J.F.R., Klippel R.A. A stereotaxic atlas of the forebrain and lower parts of the brain stem: in the rat brain. Baltimore, Williams and Wilkins, 1962.
Chirgwin J.M., Przybyla A.E., MaDonald R.J., Rutter W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294, 1979.
Davis L.G., Debner M.D., Battey J.F. Formaldehyde gel for electrophoretic separation of RNA and northern blot, Basic methods in molecular biology. Elsevier, New York, 1986.
Wade G.N., Gray J.M. Cytoplasmic 17μ-[3H] E2 in rat adipose tissues. Endocrinology 103: 1695, 1978.
Ginsburg M., Greenstein B.D., Maclusky N.J., Morris I.D., Thomas P.J. An improved method for the study of high affinity steroid binding: oE2 binding in brain and pituitary. Steroids 23: 773, 1974.
Wade G.N., Blaustein J.D. Effects of an antiestrogen on neural E2 binding and on behaviors in female rats. Endocrinology 102: 245, 1978.
Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193: 265, 1951.
Scatchard G. The attraction of proteins for small molecules and ions. Ann. N.Y. Acad. Sci. 51: 660, 1949.
Lopez F.J., Domingues J.R., Sanchez-Criado J. E., Negro-Vilar A. Distinct pulsatile PRL secretary patterns during the estrous cycle: possible encoding for diverse physiological responses. Endocrinology 124: 536, 1989.
Crowley W.R. Effect of ovarian hormones on norepinephrine and DA turnover in individual hypothalamic and extrahy-pothalamic nuclei. Neuroendocrinology 34: 381, 1982.
Blum M., McEwen B.S., Roberts J.S. Transcriptional analysis of tyrosine hydroxylase gene expression in the tuberoinfundibular DArgic neurons of the rat arcuate nucleus after estrogen treatment. J. Biol. Chem. 262: 817, 1987.
Pasqualini C., Leviel V., Guibert B., Faucon-Biguet N., Kerdelhué B. Inhibitory actions of acute E2 treatment on the activity and quantity of tyrosine hydroxylase in the median eminence of ovariectomized rats. J. Neuroendocrinology 3: 575, 1991.
Ohtsuka S., Nishizaki T., Tasaka K., Miyake A., Tanizawa O., Yamatodani A., Wada H. Estrogen stimulates gonadotropin-releasing hormone release from rat hypothalamus independently through catecholamine and histamine in vitro. Acta Endocrinol. (Copenh.) 120: 644, 1989.
Yamaguchi M., Koike K., Kadowaki A., Miyake A., Tanizawa O. Short-term treatment with 17-μ E2 enhances spontaneous [3H] DA release from cultured rat tuberoinfundibular neurons. J. Endocrinol. Invest. 14: 187, 1991.
Demarest K.T., Moore K.E. Accumulation of L-DOPA in the median eminence: an index of tuberoinfundibular DArgic nerve activity Endocrinology 106: 463, 1980.
Fuxe K., Hökfelt T., Nilssön O. Castration, sex hormones, and tuberoinfundibular DA neurons. Neuroendocrinology 5: 107, 1969.
Wiesel F.A., Fuxe K., Hökfelt T., Agnati J.L. Studies on DA turnover in ovariectomized or hypophysectmized female rats. Effects of 17β-E2 benzoate, ethynodioldi-acetate and ovine PRL. Brain Res. 148: 399, 1978.
Gudelsky G.A., Nancel D.D., Porter J.C. Role of estrogen in the DArgic control of PRL secretion. Endocrinology 108: 440, 1981.
Arita J., Kimura F. Direct inhibitory effects of long-term oE2 treatment on DA synthesis in tuberoinfundibular DArgic neurons: in vitro studies using hypothalamic slices. Endocrinology 121: 692, 1987.
Demarest K.T., Riegle G.D., Moore K.E. Long-term treatment with E2 induces reversible alternations in tuberoinfundibular DArgic neurons: a decreased responsiveness to PRL. Neuroendocrinology 39: 193, 1984.
Jones E.E., Naftonelin F. Estrogen effects on the tuberoinfundibular DArgic system in the female rat brain. Brain Res. 510: 84, 1990.
Maurer R.A. DArgic inhibition of PRL synthesis and PRL messenger RNA accumulation in cultured pituitary cells. J. Biol. Chem. 255: 8092, 1980.
Maurer R.A. Transcriptional regulation of the PRL gene by ergocryptine and cyclic AMP. Nature 294: 94, 1981.
Maurer R.A. Relationship between E2, ergocryptine, and thyroid hormone: effects on PRL synthesis and PRL messenger ribonucleic acid levels. Endocrinology 110: 1515, 1982.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Maeda, T., Ikegami, H., Sakata, M. et al. Intraventricular administration of estradiol modulates rat prolactin secretion and synthesis. J Endocrinol Invest 19, 586–592 (1996). https://doi.org/10.1007/BF03349022
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03349022